Thus, in 2006 Kaplan et al. [26] identified a mutation in activin receptor IA/activin-like kinase 2 (AVCR1/ALK2) in all patients presenting with FOP (Figure 5). The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.